Showing 12,141 - 12,160 results of 42,081 for search '(( 50 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 0.68s Refine Results
  1. 12141

    S1 Data - by Chung-Yeh Chuang (15285925)

    Published 2023
    “…In the multivariate analysis, being underweight (adjust OR [aOR], 3.80, compared to normoweight; 95% CI, 1.23–11.7) and lower maximal inspiratory airway pressure (aOR per one cmH<sub>2</sub>O decrease, 1.05; 95% CI 1.00–1.09) remained significantly associated with extubation failure.…”
  2. 12142

    Baseline characteristics of enrolled patients. by Chung-Yeh Chuang (15285925)

    Published 2023
    “…In the multivariate analysis, being underweight (adjust OR [aOR], 3.80, compared to normoweight; 95% CI, 1.23–11.7) and lower maximal inspiratory airway pressure (aOR per one cmH<sub>2</sub>O decrease, 1.05; 95% CI 1.00–1.09) remained significantly associated with extubation failure.…”
  3. 12143
  4. 12144
  5. 12145
  6. 12146

    Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  7. 12147

    Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  8. 12148

    Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  9. 12149

    Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  10. 12150

    Table_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  11. 12151
  12. 12152
  13. 12153

    Accuracy test results. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
  14. 12154

    Experiment environment and parameter. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
  15. 12155

    Test results for NME and FR. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
  16. 12156

    DARTS algorithm process. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
  17. 12157

    Comparison result of memory usage. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
  18. 12158

    LKA model structure. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
  19. 12159

    Test results on different datasets. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
  20. 12160

    Comparison result of memory usage. by Yuxuan Ji (13991895)

    Published 2025
    “…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”